Liquid Biopsy Growth nRichDX offers a high-yield liquid biopsy sample prep system that increases analyte recovery and test sensitivity for cfDNA, ctDNA, cfTNA and cfRNA, addressing a key lab pain point in NGS and PCR workflows. Target research and clinical labs expanding liquid biopsy programs, with Revolution CTC Enrichment Kit enabling isolation from up to 40 ml whole blood for assay development.

Strategic Partnerships There are active collaborations with AgenaBioScience and OraSure, plus opportunities to co-develop with CROs and academic medical centers. Leverage these relationships to cross-sell Revolution cfTNA and CTC kits and access established customer bases in urine and blood-based liquid biopsy research.

Diverse Portfolio A growing product line including Revolution Circulating Free TNA Kit, Revolution CTC Enrichment Kit and Revolution Sample Prep Service enables multi-step workflows and cross-selling across labs pursuing cfDNA, ctDNA and cfRNA assays, boosting average deal size and repeat orders.

Competitive Advantage The platform offers universal sample prep with 510K exemption and increased target material, enabling labs to reduce false negatives and streamline workflows, positioned as a strong ROI driver for liquid biopsy pipelines.

Market Expansion With a focused team and proven revenue traction, nRichDX can scale through channel partnerships and pilot programs with academic centers, clinical laboratories and CROs, including urine-based applications highlighted by OraSure collaborations.